AVITA Medical to Host Investor Webinar Briefing
VALENCIA, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ:RCEL, ASX:AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, Chief Executive Officer, and David O’Toole, Chief Financial Officer, on December 5, 2023, at 2:00 p.m. (PST) / December 6, 2023, at 9:00 a.m. (AEDT).
Related news for (RCEL)
- MoBot alert highlights: NYSE: MSN, NASDAQ: ADAP, NASDAQ: CCCC, NASDAQ: RCEL, NASDAQ: PTNM (09/15/25 12:00 PM)
- MoBot’s Stock Market Highlights – 09/15/25 11:00 AM
- MoBot alert highlights: NASDAQ: HSDT, NASDAQ: RCEL, NYSE: GPUS, NYSE: ATCH, NASDAQ: HYFT (09/15/25 06:00 AM)
- AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
- AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific